INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -84.0% | 13,691 | -69.2% | 0.00% | -100.0% |
| Q4 2021 | $100,000 | -63.1% | 44,434 | -50.9% | 0.00% | -66.7% |
| Q2 2021 | $271,000 | -63.2% | 90,500 | -60.4% | 0.00% | -66.7% |
| Q1 2021 | $737,000 | +2848.0% | 228,250 | +1615.5% | 0.01% | +800.0% |
| Q1 2019 | $25,000 | -82.3% | 13,305 | -50.3% | 0.00% | -87.5% |
| Q1 2016 | $141,000 | -28.8% | 26,772 | +6.4% | 0.01% | -33.3% |
| Q4 2015 | $198,000 | -25.6% | 25,173 | -20.1% | 0.01% | -7.7% |
| Q3 2015 | $266,000 | +58.3% | 31,501 | +105.5% | 0.01% | +62.5% |
| Q2 2015 | $168,000 | -85.2% | 15,330 | -81.2% | 0.01% | -85.7% |
| Q1 2015 | $1,137,000 | +28.3% | 81,350 | +55.0% | 0.06% | +16.7% |
| Q4 2014 | $886,000 | +2171.8% | 52,476 | +1709.5% | 0.05% | +2300.0% |
| Q3 2014 | $39,000 | – | 2,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,354,963 | $38,132,000 | 1.80% |
| Orbimed Advisors | 4,520,800 | $73,201,000 | 1.55% |
| QVT Financial LP | 1,326,610 | $21,480,000 | 1.44% |
| BB BIOTECH AG | 1,089,828 | $17,646,000 | 1.27% |
| Meditor Group Ltd | 250,000 | $4,048,000 | 0.55% |
| Perimeter Capital Partners, LLC | 159,915 | $2,589,000 | 0.50% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 156,808 | $2,539,000 | 0.43% |
| Broadfin Capital, LLC | 117,172 | $1,897,000 | 0.37% |
| OXFORD ASSET MANAGEMENT LLP | 811,331 | $13,184,000 | 0.36% |
| Baker Brothers Advisors | 1,016,433 | $16,458,000 | 0.33% |